| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |